TAKEDA PHARMACEUTICAL CO LTD
NYSE · Pharmaceutical Preparations
Company Overview
A concise company profile alongside the latest public filing activity.
Takeda Pharmaceutical is a Japan-based drugmaker that develops and sells prescription medicines in areas including gastroenterology, rare diseases, plasma-derived therapies, oncology, and neuroscience, marketing its products globally.
Company profile sourced from SEC filings.
Corporate Insider Trades
Open-market purchases and sales by directors, officers, and other company insiders.
| Insider | Type | Value | Shares / Price | Date |
|---|---|---|---|---|
| Plump Andrew StewartPresident, R&D | Sell | $2.15M | 116,191at $18.49 | Sep 2, 2026 |
| Kim Julie So-YoungPresident and CEO | Sell | $1.52M | 89,090at $17.10 | Aug 10, 2026 |
| Bitetti Teresa MariePresident, OBU | Sell | $855K | 50,012at $17.10 | Aug 10, 2026 |
| Duprey Lauren RusckowskiChief Transformation Officer | Sell | $814K | 47,586at $17.10 | Aug 10, 2026 |
| Platford Giles RichardPresident, IBU | Sell | $532K | 31,083at $17.10 | Aug 10, 2026 |
| Furney Natalie Anne MarieGlobal General Counsel | Sell | $528K | 30,868at $17.10 | Aug 10, 2026 |
| Ricci GabrieleChief Data & Tech. Officer | Sell | $429K | 25,088at $17.10 | Aug 10, 2026 |
| Plump Andrew StewartPresident, R&D | Sell | $2.83M | 165,393at $17.10 | Aug 10, 2026 |
| Pacheco Rhonda JanicePresident, U.S. Business Unit | Sell | $289K | 16,901at $17.10 | Aug 10, 2026 |
| Farajallah Awny Samaan BotrosChief Medical Officer | Sell | $240K | 14,006at $17.10 | Aug 10, 2026 |
| Ibrahim Ramy Riad AhmedPresident, PDT BU | Sell | $124K | 7,277at $17.10 | Aug 10, 2026 |
| Greenway Nicola Deidre PetalChief Human Resources Officer | Sell | $116K | 6,774at $17.10 | Aug 10, 2026 |
| Shannon Elaine MaryPres., Global Supply & Quality | Sell | $68K | 3,978at $17.10 | Aug 10, 2026 |
| Pignagnoli Agosti MarcelloHead, Strat. & Port. Dev | Sell | $393K | 22,957at $17.10 | Aug 10, 2026 |
Source: SEC EDGAR Form 4 filings
Congressional Trades
Recent disclosures by members of the U.S. House and Senate.
Source: Senate eFD and House Clerk STOCK Act disclosures
Get notable TAK activity by email
Free alerts for the insider and congressional trades worth watching.
For informational purposes only, not investment advice. Filings can be delayed, corrected, or amended. Trading activity alone does not predict future performance.